SevenBridge Financial »

Xilio Therapeutics shares owned by SevenBridge Financial

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by SevenBridge Financial from 13F filings

Historical chart of SevenBridge Financial investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by SevenBridge Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by SevenBridge Financial

Quarter filed Position value Share count Share price at filing
2024-06-30 $37k 41k 0.91
2024-03-31 $37k 31k 1.18

More positions owned by SevenBridge Financial

Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr Iboxx Inv Cp Etf (LQD)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
Pepsi (PEP)
Hershey Company (HSY)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Johnson & Johnson (JNJ)
Oracle Corporation (ORCL)
Exxon Mobil Corporation (XOM)

View all positions for SevenBridge Financial

Top funds holding Xilio Therapeutics

Bain Capital Life Sciences Investors
Rock Springs Capital Management
RiverVest Venture Management
Morgan Stanley
Vanguard Group
Renaissance Technologies
Balyasny Asset Management
Geode Capital Management
Bridgeway Capital Management
BlackRock
State Street Corporation
SevenBridge Financial
Raymond James & Associates
XTX Topco
Honkamp Krueger Financial Services

View all funds holding Xilio Therapeutics